Polyzois Makras

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 29

Top Venues

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Journal of clinical medicine

Biomedicines

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

251 General Air Force Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

251 General Air Force Hospital

Greece

Deputy Director :: Dpt of Endocrinology & Diabetes

Publications

Andrea Palermo, Gaia Tabacco, Polyzois Makras, Guido Zavatta, Pierpaolo Trimboli, Elena Castellano, Maria P Yavropoulou, Anda Mihaela Naciu, Athanasios D Anastasilakis
Primary hyperparathyroidism: from guidelines to outpatient clinic. Reviews in endocrine & metabolic disorders (2024)
Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, Matthaios Savvidis, Christos S Mantzoros
The comparative effect of teriparatide and denosumab on activins, follistatins and inhibins in women with postmenopausal osteoporosis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2024)
Athanasios D Anastasilakis, Maria P Yavropoulou, Andrea Palermo, Polyzois Makras, Julien Paccou, Gaia Tabacco, Anda Mihaela Naciu, Elena Tsourdi
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when? European journal of endocrinology 191 (1) (2024)
Athanasios D Anastasilakis, Maria P Yavropoulou, Andrea Palermo, Polyzois Makras, Julien Paccou, Gaia Tabacco, Anda Mihaela Naciu, Elena Tsourdi
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when. European journal of endocrinology (2024)
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Christos Tekedis, Socrates E Papapoulos
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (4) (2023)
Athanasios D Anastasilakis, Polyzois Makras, Julien Paccou, Ilias Bisbinas, Stergios A Polyzos, Socrates E Papapoulos
Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab. Journal of clinical medicine 12 (18) (2023)
Polyzois Makras, Maria P Yavropoulou, Sofia N Chatziioannou, Athanasios D Anastasilakis, Danai Georgakopoulou, Marina Tsoli, Eleftherios Chatzelis, Grigorios Kaltsas
Efficacy of denosumab monotherapy among adults with Langerhans cell histiocytosis: A prospective clinical trial. American journal of hematology (2023)
Polyzois Makras, Maria P Yavropoulou, Stergios A Polyzos, Socrates E Papapoulos, Danai Georgakopoulou, Athanasios Papatheodorou, Athanasios D Anastasilakis
The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Athanasios D Anastasilakis, Stergios A Polyzos, Panagiotis A Vorkas, Athina Gkiomisi, Maria P Yavropoulou, Martina Rauner, Panagiotis Nikolakopoulos, Stergios Papachatzopoulos, Polyzois Makras, Spyridon Gerou, Lorenz C Hofbauer, Andrea Palermo, Elena Tsourdi
Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study. Journal of clinical medicine 12 (16) (2023)
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Christos Tekedis, Socrates E Papapoulos
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (4) (2023)
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Christos Tekedis, Socrates E Papapoulos
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Christos Tekedis, Socrates E Papapoulos
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 35 (4) (2023)
Souliotis Kyriakos, Christina Golna, Christina Poimenidou, Tatiana Drakopoulou, Memi Tsekoura, Damon Willems, Vasileios Kountouris, Polyzois Makras
Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece. Patient preference and adherence 17 (2023)
Souliotis Kyriakos, Christina Golna, Christina Poimenidou, Tatiana Drakopoulou, Memi Tsekoura, Damon Willems, Vasileios Kountouris, Polyzois Makras
Disease Burden and Treatment Preferences Amongst Postmenopausal Women with Severe Osteoporosis in Greece. Patient preference and adherence 17 (2023)
Gaurav Goyal, Abdellatif Tazi, Ronald S Go, Karen L Rech, Jennifer L Picarsic, Robert Vassallo, Jason R Young, Christian W Cox, Jan A M van Laar, Michelle L Hermiston, Xin-Xin Cao, Polyzois Makras, Grigorios Kaltsas, Julien Haroche, Matthew Collin, Kenneth L McClain, Eli L Diamond, Michael Girschikofsky
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood 139 (17) (2022)
Dimitra Stathi, Maria P Yavropoulou, Carl E Allen, Harshal Abhyankar, Brooks Scull, Marina Tsoli, Evangelos Andreakos, Grigorios Kaltsas, Polyzois Makras
Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis. Pediatric hematology and oncology 39 (6) (2022)
Danae Georgakopoulou, Athanasios D Anastasilakis, Polyzois Makras
Adult Langerhans Cell Histiocytosis and the Skeleton. Journal of clinical medicine 11 (4) (2022)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Eirini Katodritou, Marie-Christine Kyrtsonis, Vassiliki Douka, Emmanouil Spanoudakis, Athanasios Papatheodorou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Maria Gavriatopoulou, Polyzois Makras, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study. Cancers 13 (6) (2021)
Athanasios D Anastasilakis, Stergios A Polyzos, Maria P Yavropoulou, Natasha M Appelman-Dijkstra, Charikleia Ntenti, Stylianos Mandanas, Athanasios Papatheodorou, Polyzois Makras
Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation. Calcified tissue international 108 (5) (2021)
Polyzois Makras, Natasha M Appelman-Dijkstra, Socrates E Papapoulos, Sandra van Wissen, Elizabeth M Winter, Stergios A Polyzos, Maria P Yavropoulou, Athanasios D Anastasilakis
The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation. The Journal of clinical endocrinology and metabolism 106 (10) (2021)
Athanasios D Anastasilakis, Polyzois Makras, Maria P Yavropoulou, Gaia Tabacco, Anda Mihaela Naciu, Andrea Palermo
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review. Journal of clinical medicine 10 (1) (2021)
Maria P Yavropoulou, Artemis Kolynou, Polyzois Makras, Maria Pikilidou, Sideris Nanoudis, Lemonia Skoura, Olga Tsachouridou, Georgios Ntritsos, Alexandros T Tzallas, Dimitrios G Tsalikakis, Olga Tsave, Simeon Metallidis, Dimitrios Chatzidimitriou
Circulating microRNAs Related to Bone Metabolism in HIV-Associated Bone Loss. Biomedicines 9 (4) (2021)
Polyzois Makras, Maria P Yavropoulou, Evanthia Kassi, Athanasios D Anastasilakis, Andromachi Vryonidou, Symeon Tournis
Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society. Hormones (Athens, Greece) 19 (4) (2020)
Maria P Yavropoulou, Vasilios Vaios, Polyzois Makras, Panagiotis Georgianos, Anastasios Batas, Dimitrios Tsalikakis, Alexandros T Tzallas, Georgios Ntritsos, Roumeliotis Stefanos, Theodoros Eleftheriadis, Vasillios Liakopoulos
Expression of Circulating MicroRNAs Linked to Bone Metabolism in Chronic Kidney Disease-Mineral and Bone Disorder. Biomedicines 8 (12) (2020)
Polyzois Makras, Athanasios D Anastasilakis
Questions and facts regarding denosumab discontinuation among postmenopausal women. Expert opinion on drug safety 20 (5) (2020)
Maria P Yavropoulou, Kalliopi Pazaitou-Panayiotou, John G Yovos, Christos Poulios, Athanasios D Anastasilakis, Dimitris Vlachodimitropoulos, Kyriakos Vambakidis, Olga Tsave, Sofia Chrisafi, Emily Daskalaki, Polyzois Makras
Circulating and Tissue Expression Profile of MicroRNAs in Primary Hyperparathyroidism Caused by Sporadic Parathyroid Adenomas. JBMR plus 5 (2) (2020)
Polyzois Makras, George C Babis, Efstathios Chronopoulos, Theophilos Karachalios, Konstantinos Kazakos, Dionysios Paridis, Michael Potoupnis, Anastasios-Nektarios Tzavellas, Christos Valkanis, Christos Kosmidis
Experience gained from the implementation of the fracture liaison service in Greece. Archives of osteoporosis 15 (1) (2020)
Polyzois Makras, Dimitra Stathi, Maria Yavropoulou, Marina Tsoli, Gregory Kaltsas
The annual incidence of Langerhans cell histiocytosis among adults living in Greece. Pediatric blood & cancer 67 (9) (2020)
Athanasios D Anastasilakis, Socrates E Papapoulos, Stergios A Polyzos, Natasha M Appelman-Dijkstra, Polyzois Makras
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 34 (12) (2019)

Polyzois Makras.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Polyzois Makras